EMPAGLIFLOZIN REDUCES MORTALITY AND HOSPITALIZATION FOR HEART FAILURE IN PATIENTS WITH OR WITHOUT A HISTORY OF MYOCARDIAL INFARCTION OR STROKE AT BASELINE
Fitchett, D., Inzucchi, S., Sambevski, S., Kaspers, S., Pfarr, E., George, J., Zinman, B.Volume:
34
Journal:
Canadian Journal of Cardiology
DOI:
10.1016/j.cjca.2018.07.288
Date:
October, 2018
File:
PDF, 542 KB
2018